Sanofi Aventis Pakistan Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sanofi Aventis Pakistan Ltd with three other
companies in this sector in PAKISTAN :
Searle Co Ltd
sales of 18.06 billion Pakistan Rupees [US$109.10 million]
of which 79%
Glaxosmithkline Consumer Healthcare Pakistan Ltd
(16.32 billion Pakistan Rupees [US$98.55 million]
of which 100%
was Consumer HealthCare), and
Highnoon Laboratories Limited
(9.05 billion Pakistan Rupees [US$54.65 million]
During the year ended December of 2019, sales at
Sanofi Aventis Pakistan Ltd were 14.50 billion Pakistan Rupees (US$87.58 million).
increase of 11.9%
versus 2018, when the company's sales were 12.96 billion Pakistan Rupees .
This was the fifth consecutive year of sales increases at Sanofi Aventis Pakistan Ltd
(and since 2014, sales have increased a total of 46%).